Generally, patients with IPF are well known to exhibit elevated serum KL-6, SP-D, and LDH levels, and these levels are also recognized as predictive biomarkers of survival of these patients [4]. The gene discussed is SFTPD; the disease is idiopathic pulmonary fibrosis.